| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Knell Michael Gunnar | CSVP, CAO, Interim CFO | C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE STREET, WILMINGTON | /s/ Michael G. Knell | 07 Nov 2025 | 0001543779 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRL | Common Stock | Award | $499,995 | +2,926 | +28% | $170.88 | 13,460 | 06 Nov 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | 50% of the unvested restricted stock units vest on November 6, 2026, with the remaining 50% vesting on November 6, 2027. |